title: [Results of the intraocular lens SI-30 implantation].
abstract: OBJECTIVE
  clinical evaluation of the flexible silicone intraocular lens SI-30 (Allergan).
  
  
  METHODS
  retrospective study over 3 years of 2000 implantations of the SI-30 IOL. The lenses were inserted through a 3.2 mm scleral tunnel and placed in the capsular bag after continuous circular capsulorhexis and phacoemulsification.
  
  
  RESULTS
  visual outcome was excellent. Without other causes of impaired vision, 99% of patients regained a visual acuity of 20/30 or better after 1 month. Induced astigmatism was unsignificant: 0.4 D; preop., 0.9 D. at day 7, 0.4 at 1 month, 0.5 D. at 1 year. A disinsertion of the inferior haptic occurred in 2 cases during the insertion manoeuver. More specific postoperative complications consisted of pigmented deposits (less than 1%), pupillary capture (4 cases), and capsule contraction associated with small size capsulorhexis. Aspecific complications were: cystoid macular oedema (3% at 1 month, less than 1% afterwards), chronic uveitis (0.6%), acute uveitis (1 patient).
  
  
  CONCLUSIONS
  implantation of the SI-30 silicone lens is safe and gives the patient the benefits of a small, non enlarged, and sutureless cataract incision. The postoperative follow-up must take in account the properties of the lens.
authors.affiliation: Hôpital Universitaire St. Luc, U.C.L., Bruxelles.
authors.forename: J M
authors.initials: JM
authors.lastname: Lemagne
mesh_terms: D019923:Capsulorhexis; D006801:Humans; D007910:Lenses, Intraocular / Q000009:adverse effects / Q000592:standards*; D008269:Macular Edema / Q000209:etiology; D018918:Phacoemulsification; D011474:Prosthesis Design; D012189:Retrospective Studies; D012828:Silicones; D016896:Treatment Outcome; D014605:Uveitis / Q000209:etiology; D014792:Visual Acuity
chemical_list: D012828:Silicones